|1.||Gazzolo, Diego: 13 articles (01/2015 - 02/2002)|
|2.||Michetti, Fabrizio: 9 articles (09/2006 - 02/2002)|
|3.||Esposito, Giuseppe: 6 articles (01/2015 - 09/2007)|
|4.||Psachoulia, Christina: 6 articles (10/2013 - 08/2004)|
|5.||Lituania, Mario: 6 articles (09/2006 - 02/2002)|
|6.||Marinoni, Emanuela: 6 articles (09/2006 - 02/2002)|
|7.||Cuomo, Rosario: 5 articles (01/2015 - 09/2007)|
|8.||Sarnelli, Giovanni: 5 articles (01/2015 - 09/2007)|
|9.||Steardo, Luca: 5 articles (01/2015 - 06/2008)|
|10.||Souza, Diogo O: 5 articles (12/2007 - 12/2004)|
|1.||Melanoma (Melanoma, Malignant)
04/01/1999 - "Recent reports on the use of a quantitative measurement of S100B protein for the detection of metastatic melanoma have yielded promising results. "
01/01/2009 - "Prognostic significance of serum S100B protein in high-risk surgically resected melanoma patients participating in Intergroup Trial ECOG 1694."
01/01/2007 - "S-100beta serum determination should be considered to be included in clinical trials that test adjuvant therapies in melanoma patients."
01/01/2007 - "High S-100beta levels (during therapy) showed a relation with positive lymph node status (p = 0.014), number of positive lymph nodes (p = 0.01), macroscopic lymph node involvement (p = 0.002) and second melanoma diagnosis at study entry (p = 0.001). "
01/01/2007 - "It was the aim of this study to analyze the clinical value of the determination of serum S-100beta protein in high-risk melanoma patients. "
|2.||Brain Injuries (Brain Injury)
08/31/2001 - "The increased levels of S-100beta seen after brain injury and in certain neurological and psychiatric disorders may be considered as beneficial for brain recovery."
01/01/2010 - "The prognostic value of the temporal course of S100beta protein in post-acute severe brain injury: A prospective and observational study."
01/01/2006 - "The aim of the present study was to clarify, whether intravenous application of endotoxin results in neuropathological findings and increased blood levels of the S100B protein, which is a consolidated marker of brain injury. "
07/01/2003 - "The objective of this study was to obtain data to further define the extent of traumatic brain injury by using S-100B protein and standard noncontrast magnetic resonance imaging with added fluid-attenuated inversion recovery (FLAIR) and gradient echo sequence in children with normal head computed tomography. "
12/01/2000 - "This finding supports the results of previous studies suggesting the potential accuracy of S-100beta in the prediction of brain injury after cardiac surgery."
01/01/2003 - "Fifty-nine patients were included in this study; serum S-100B protein was measured using an immunoluminometric assay while the expression pattern in the primary tumor was determined by immunohistochemistry using an anti-S-100B monoclonal antibody. "
01/01/2010 - "Based on the three-dimensional structure of a carboxyl-terminal peptide of p53 in complex with the S100B protein, which is involved in regulation of the tumor suppressor activity, a model of wild type (WT) and mutant extreme CTD was developed by molecular modeling and molecular dynamics simulation. "
11/01/2005 - "In patients whose tumors are > 1 mm thickness, regular lymph node ultrasound examinations and determination of serum tumor marker S-100beta protein are commonly used by physicians in Germany. "
01/01/2004 - "[Role of S100B protein in neoplasms and other diseases]."
09/14/2001 - "S100B protein associates with both the p53 oligomerization domain (residues 325-355) and the extreme C terminus of the tumor suppressor p53 (residues 367-392). "
|4.||Schizophrenia (Dementia Praecox)
06/01/1999 - "Our findings indicate that patients with schizophrenia may suffer ongoing structural damage to cells of the central nervous system, and that the concentration of S-100b protein in plasma may help to identify clinical subgroups in schizophrenia."
01/01/2001 - "Increased serum S100B protein in schizophrenia: a study in medication-free patients."
06/01/2010 - "REMOVAL: Elevated serum S100B protein in first-episode drug-naïve Chinese patients with schizophrenia. "
06/03/2013 - "These results reinforce the idea that the S100B protein is involved in the inflammatory response observed in many brain diseases, including schizophrenia. "
08/01/2013 - "While plasma levels of agmatine in patients with schizophrenia were significantly increased (p < 0.0001) compared to those of healthy individuals (control), there were no significant changes in the levels of S100B protein (p = 0.660). "
|5.||Alzheimer Disease (Alzheimer's Disease)
06/01/2008 - "Previous studies suggest that levels of the astrocyte-derived S100B protein, such as those occurring in brain extra-cellular spaces consequent to persistent astroglial activation, may have a pathogenetic role in Alzheimer's disease (AD). "
01/01/2015 - "Among the different signaling molecules released during reactive gliosis occurring in Alzheimer's disease (AD), the astrocyte-derived S100B protein plays a key role in neuroinflammation, one of the hallmarks of the disease. "
03/29/2005 - "S100B protein is elevated in the brains of patients with early stages of Alzheimer's disease and Down's syndrome. "
06/18/1999 - "The S100beta protein is overexpressed in the brain of patients with Alzheimer's disease and Down's syndrome and is able to induce apoptosis in neurons at high concentrations. "
01/01/2005 - "As for tau protein and beta-amyloid(1-42) (Abeta42), promising results for the diagnosis of Alzheimer's disease (AD) have been reported; we evaluated these markers and S-100B protein in cerebrospinal fluid (CSF), using a set of commercially available assays, of 71 patients with DLB, 67 patients with AD and 41 nondemented controls (NDC) for their differential diagnostic relevance. "
|1.||Monophenol Monooxygenase (Tyrosinase)
|3.||tau Proteins (tau Protein)
|4.||Carrier Proteins (Binding Protein)
|5.||Biological Tumor Markers (Tumor Markers)
|6.||Biological Markers (Surrogate Marker)
|7.||Phosphopyruvate Hydratase (Enolase)
|9.||L-Lactate Dehydrogenase (Lactate Dehydrogenase)
|10.||Interleukin-6 (Interleukin 6)
|3.||Cardiopulmonary Bypass (Heart-Lung Bypass)